Editors' ChoiceCancer Loss of TET2 boosts cell fitness Chiara GiannarelliCardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Email: chiara.giannarelli{at}mssm.edu See allHide authors and affiliations Science Translational Medicine 22 Jul 2020:Vol. 12, Issue 553, eabd3619DOI: 10.1126/scitranslmed.abd3619 Chiara Giannarelli Cardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: chiara.giannarelli@mssm.edu Article Info & Metrics eLetters AbstractThe loss of TET2 favors a pathogenic switch to a stem cell–like state in cancer.Copyright © 2020, American Association for the Advancement of ScienceView Full Text
Loss of TET2 boosts cell fitness By Chiara Giannarelli Science Translational Medicine22 Jul 2020 The loss of TET2 favors a pathogenic switch to a stem cell–like state in cancer.
Loss of TET2 boosts cell fitness By Chiara Giannarelli Science Translational Medicine22 Jul 2020 The loss of TET2 favors a pathogenic switch to a stem cell–like state in cancer.